Department of Translational Imaging in Oncology
The Department of Translational Imaging in Oncology aims to enhance clinical research into new therapies by using and developing imaging techniques. The focus is on the role of imaging in clinical decision-making processes, such as combining systemic and local therapeutic approaches, and the value of functional imaging in managing individual therapies.
High-quality anatomical and functional imaging will support clinical trials and registries. The spread and biological characteristics of diseases will be imaged non-invasively using innovative and accurate methods for different types of cancer.
PET/MRI and PET/CT imaging will therefore be developed further in the following ways:
- Understanding derived parameters of tumour distribution, tumour volume and tumour configuration.
- Imaging functional processes in the tumour to inform the choice of the most appropriate individualised tumour therapy.
Contact
Prof. Dr. med. Matthias Miederer
Head of the Department of Translational Imaging in Oncology
email: matthias.miederer(at)nct-dresden.de
2025
Staging metastatic urothelial cancer with Nectin-4 imaging using Gallium-68-N188 PET/CT
Miederer M, Pretze M, Abbate E, Hartig A, do Mar Ferreira Machado J, Bohm K, Sommer U, Hoberuck S, Bundschuh RA, Kotzerke J, and Thomas C. BJU Int. 2025 Aug 23. doi: 10.1111/bju.16901.
Imaging-derived biomarkers from (68)Ga-DOTATOC PET/CT scans to predict survival of patients with neuroendocrine tumors after PRRT with (177)Lu-DOTATATE
Raad S, Al-Fatlawi A, Wise CL, Fottner C, Schadmand-Fischer S, Schreckenberger M, Weber MM, TMusholt TJ, Schroeder M and Miederer M. Cancer Imaging 2025 Jul 1;25(1):81. doi: 10.1186/s40644-025-00899-5.
2024
Prognostic value of metabolic tumor volume on [(18)F]FDG PET/CT in addition to the TNM classification system of locally advanced non-small cell lung cancer.
Brose A, Miederer I, Konig J, Gkika E, Sahlmann J, Schimek-Jasch T, Schreckenberger M, Nestle U, Kappes J and Miederer M. 2024, Cancer Imaging, 24: 171. doi: 10.1186/s40644-024-00811-7
2023
Genetic Code Expansion for Site-Specific Labeling of Antibodies with Radioisotopes.
Koehler C, Sauter PF, Klasen B, Waldmann C, Pektor S, Bausbacher N, Lemke EA, Miederer M. ACS Chem Biol. 2023 Mar 8. doi: 10.1021/acschembio.2c00634.
Up-Regulation of PSMA Expression In Vitro as Potential Application in Prostate Cancer Therapy.
Runge R, Naumann A, Miederer M, Kotzerke J, Brogsitter C. Pharmaceuticals (Basel). 2023 Apr 4;16(4):538. doi: 10.3390/ph16040538
PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohort.
Brose A, Michalski K, Ruf J,Tosch M, Eschmann SM, Schreckenberger M, König J, Nestle U, Miederer M. Cancer Imaging 23, 45 (2023). https://doi.org/10.1186/s40644-023-00567-6
Link to page "NCT/UCC Imaging Platform" with further information